Chiron Shareholders Approve Novartis Acquisition.

EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ NASDAQ
in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CHIR CHIR Chiricahua National Monument (US National Park Service) ) today announced that Chiron shareholders have approved the amended merger agreement under which Novartis AG (NYSE NYSE

See: New York Stock Exchange :NVS NVS - Non-Volatile Storage ) will acquire all Chiron shares it doesn't already own for $48.00 per share in cash. At a special meeting of Chiron shareholders held today, the merger was approved with more than 85 percent of Chiron's total outstanding shares cast in favor of the merger.

As all necessary regulatory approvals were previously received, Chiron expects the merger to close on Thursday, April 20, 2006, at 12:01 a.m. PDT.

About Chiron

Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information about Chiron, please visit www.chiron.com.

COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Apr 19, 2006
Words:	143
Previous Article:	Trustmark Launches Voluntary Dental Enhancements; New plan designs and benefits offer greater flexibility.
Next Article:	Liquidnet Dominates the Market's Block Trading; Two out of Every Three Names Executed in Liquidnet are 1st or 2nd Largest Print of the Day.
Topics:	Biological products industry Mergers, acquisitions and divestments Pharmaceutical industry Mergers, acquisitions and divestments

Related Articles
MARKETING NEWS.
DRUG GIANTS TO MERGE\Ciba, Sandoz to pool biotech research efforts.
LION GETS NEW AND UPGRADED LICENSES FOR SRS.
BRIEFCASE.
Chiron Announces Merger Agreement with Novartis; Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per Share in Cash; Agreement...
ValueAct Capital to Vote against Novartis Acquisition of Chiron.
Chiron Receives European Commission Approval for Proposed Merger With Novartis.
CHIRON GETS PANDEMIC INFLUENZA VACCINE CONTRACT WITH U.K.
Chiron Announces Amended Merger Agreement with Novartis; Novartis to Acquire All Outstanding Chiron Shares for $48.00 Per Share in Cash.
Proxy Advisory Services Recommend Shareholders Vote in Favor of Chiron's Amended Merger Agreement with Novartis.